Research
Micronutrients & recovery
Personalized prevention strategies using biomarkers (genetics, omics, imaging) are necessary to predict individual response to lifestyle interventions and optimize cardiovascular risk reduction.
Current risk assessments may not be precise enough for everyone. Future care may involve genetic or biomarker testing to predict exactly which lifestyle changes (diet, exercise type/intensity) will work best for you, moving away from a one-size-fits-all approach.
ModerateSupportsMEDIUM confidence
Characterization of biomarkers with prognostic potential to predict high-risk patients will have to be added by the identification of 'modifiable biomarkers', which characteristically change by intervention strategies and predict efficacy of intervention. Optimally, assessment of these parameters... will predict the most effective intervention with the highest probability of success in reducing cardiovascular morbidity and mortality
Why this rating
Based on observational cohort data (UK Biobank, German National Cohort) and proposed trial designs (OptimEx), not yet large-scale RCT results for personalized biomarker-guided lifestyle therapy.
Source
Research in preventive cardiology: Quo vadis?
Martin Halle · European Journal of Preventive Cardiology · 2020
narrative_reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →